Book The Billionaire World Hanne Nabintu Herland How Marxism Serves the Elite
Cancer Tsunami expected from 2025: Shocking Study on COVID Vaccines: PAHO

New Cancer Tsunami expected from 2025: Those younger than 50 are most affected, spiking since the Covid vaccines began in 2021

 

An alarming increase in cancer among younger Americans, noteworthy those under 50, is set to top 2 million individuals in 2024, according to new American Cancer Society data.

Cancer Tsunami expected from 2025: With the highest projections of cancer instances in history, where those younger than 50 are most affected, spiking since the Covid vaccines began in 2021, many suspect a cover up to hide its origin.

Adverse reactions against the un-properly tested and rushed vaccines are by now well known, yet there is a remarkable refusal from the jab producers and medical faculties to publicly connect the vaccines to the reactions. And now, the astronomical surge in “turbo cancers”.

Simply put, doctors and producers point out that cancers are exploding since 2021, yet state that nobody has any clue why.

“It seems the population is the last to know, but everyone from the largest pharmaceutical companies, to politicians, and healthcare providers are all betting on a tsunami of cancers starting in 2025.

Johnson & Johnson is just the latest company to secure a piece of the pie, now that they’ve paid a $700 million settlement for the Talc baby powder scandal. And they overpaid the latest acquisition by more than 100% of the current stock price,” writes Dr. William Makis, a Canadian physician with expertise in Radiology, Oncology and Immunology.

 

Cancer Tsunami expected from 2025: Herland Report banner Newsletter
Cancer Tsunami expected from 2025: The level of censorship in social media and search engines is all-time high. Do like thousands of others, subscribe to The Herland Report newsletter here! Thanks so much for reading and supporting our investigative work. Follow the trend and subscribe! 

 

Cancer Tsunami expected from 2025: Axios reports: There have been major improvements in cancer survival, but there’s a worrying rise in some cancers at the same time doctors are trying to figure out why they’re seeing more young patients with cancer.

This demographic shift comes with psychological, physical and financial burdens that are less common with older patients, experts say.

  • Patients under 50 are more likely to be uninsured, juggling career and caregiving responsibilities, and face a higher lifetime risk of treatment-related side effects like second cancers.
  • “It’s overwhelming for anybody, but especially for these younger patients who are going on with their daily lives and then suddenly get this life-altering diagnosis and really don’t know where to turn,” Robin Mendelsohn, co-director of the Center for Young Onset Colorectal and Gastrointestinal Cancers at Memorial Sloan Kettering, told Axios.
  • “Many feel alone because they’re younger, their friends, many haven’t had to deal with this.”

 

RELATED ARTICLES:

 

“Notably, people aged younger than 50 years were the only one of these three age groups to experience an increase in overall cancer incidence during this time period,” the ACS report said.  The study projects cancer will kill nearly 612,000 people this year, up from a projected 609,820 in 2023. Read the full article here. 

Cancer Tsunami expected from 2025: Dr. William Makis, a Canadian physician with expertise in Radiology, Oncology and Immunology. Governor General’s Medal, University of Toronto Scholar, author of over 100 peer-reviewed medical publications, recently wrote an article at Covid Intel, about the surge in cancers post 2021.

“Johnson & Johnson to acquire $2 billion drug developer “Ambrx Biopharma” to treat Turbo Cancers with same tech as Pfizer’s $43 billion Seagen acquisition. Both set their sights on 2025 Cancer Tsunami.

Many pharmaceutical companies are rushing to position themselves to profit from treating a tsunami of cancers that they are all expecting to hit starting in 2025.

  • Dec. 14, 2023 – Pfizer closed a $43 billion acquisition to treat several turbo cancers on Dec.14, 2023 and expects to “fill a gap” for the period 2025-2030.
  • Dec. 14, 2023 – Moderna targets new mRNA Cancer vaccine to treat melanoma to be available by 2025
  • Jan. 8, 2024 – Johnson & Johnson to acquire $2 billion cancer drug company that uses same tech as Pfizer, to “fill a revenue gap in 2025”
  • Jan. 10, 2024 – BioNTech expects to return to revenue growth in 2025, when its COVID vaccine business would bottom out, and it would invest to “scale up its oncology business thereafter”
  • Oct.12, 2023 – Dxcover targets 2025 launch for blood test that uses light to detect brain cancer
  • Sep.2023 – Harbinger Health raises $140M to study blood-based cancer screening test – ahead of a planned launch in 2025.
  • Jun.1, 2023 – Multi-cancer blood test shows real promise in NHS study – NHS in England plans to extend the rollout to a further one million people in 2024 and 2025

Cancer Centers to Open by 2025

  • Aug. 2023 – Cape Breton (NS, Canada) Cancer centre to open in 2025
  • Jul. 2023 – $120M Cancer center (Tennessee Oncology) set for 2025 finish
  • Jun. 2023 – $200M Cancer center set to open in NJ in 2025
  • Mar. 2023 – Orange County’s only cancer specialty hospital will open in 2025
  • May 2023 – Kearney, Nebraska to welcome new cancer center in 2025
  • Jan. 2023 – OU Health to open cancer center in 2025
  • Dec. 2022 – $2 billion Alberta, Canada cancer centre to open in 2024
  • Aug. 2022 – Baltimore, MD – Sinai Hospital to build cancer center by 2025
  • Jul. 2022 – Wales – New Velindre cancer centre to open in 2025
  • Dec. 2023 – 123 cancer centers opening, expanding, affiliating in 2023

It seems the population is the last to know, but everyone from the largest pharmaceutical companies, to politicians, and healthcare providers are all betting on a tsunami of cancers starting in 2025.

Johnson & Johnson is just the latest company to secure a piece of the pie, now that they’ve paid a $700 million settlement for the Talc baby powder scandal. And they overpaid the latest acquisition by more than 100% of the current stock price.” Read the full article here.

 

The level of censorship in social media and search engines is all-time high. Do like thousands of others, subscribe to The Herland Report newsletter here!

Led by Scandinavian bestselling author, Hanne Nabintu Herland, The Herland Report provides independent analysis from leading Western intellectuals and ground breaking YouTube interviews, cutting through the mainstream media rhetoric. It is a great place to watch interviews and read the articles of leading intellectuals, thought leaders, authors and activists from across the political spectrum. The Herland Report believes in freedom of speech and its editorial policy resides above the traditional Left vs Right paradigm which we believe has lost its relevance and ability to describe the current driving forces in Western politics.

 

Herland Report Newsletter Subscribe

Check Also

The Marxist West: Marxist America: Herland Report

Western Marxist “Liberalism” is vastly different from Traditional Liberalism – John Locke

  Let us take a closer look at how some of our well-known Western values …

Christian Values: Diminishing respect for Christianity in Israel?Reuters

Christian Values formed Western Civilization: Equality, individualism, empathy, human dignity

  In a world where the Western media chronically demonizes religion and Christian values, let …

Book The Billionaire World Hanne Nabintu Herland How Marxism Serves the Elite